Polymorphisms in folate pathway and pemetrexed treatment outcome in patients with malignant pleural mesothelioma

Pubblicato online: 25 apr 2014

Pagine: 163 - 172

Ricevuto: 12 ott 2013

Accettato: 23 ott 2013

DOI: https://doi.org/10.2478/raon-2013-0086

Parole chiave

mesothelioma, pemetrexed, polymorphism, folate pathway, toxicity

© by Vita Dolzan

This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.